DNA modifications are epigenetic marks added directly to DNA bases that can stably or dynamically regulate gene expression, allowing cells to maintain their identity while also having flexibility to adapt to changes in their environment1. Aging is often thought to disrupt this regulation, causing cells to lose their id...
Sarah R. Ocañas, Walker Hoolehan, Kevin Pham et al.· bioRxiv· 0 citations
BACKGROUND: The cardiac isoform of phosphofructokinase-2/fructose 2,6-biphosphatase (PFKFB2) is the heart’s strongest glycolytic regulator but is degraded in the absence of insulin signaling. This makes PFKFB2 loss critical to understand in metabolic heart disease, of which impaired insulin signaling is a hallmark. Pro...
Kylene M. Harold, Harris E. Blankenship, Keaton E. Minor et al.· Circulation: Arrhythmia and...· 0 citations
It is demonstrated that pTau triggers phenotypes reflective of LC-NE hyperactivity in the early stages of AD pathogenesis, laying the foundation for the development of LC-based disease-modifying therapies to address neuropsychiatric manifestations.
Anuradha Korukonda, Harris E. Blankenship, K. Kam et al.· bioRxiv· 3 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.